Status:
ACTIVE_NOT_RECRUITING
WhatsApp Intervention to Assess the Effect of Messages in Adherence to Antiretrovirals in Young People With HIV in Peru
Lead Sponsor:
Universidad Peruana Cayetano Heredia
Conditions:
HIV
Eligibility:
All Genders
18-29 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to learn which type of messages is more efficacious to improve adherence to medication in young people living with HIV. The main question is aims to answer is: -Are...
Eligibility Criteria
Inclusion
- People living with HIV of age 18-29 at the moment of signing informed consent.
- Being a patient of the study center's Infectious Diseases clinic or National HIV Program, between March 2024 and July 2024.
- Ownership of a mobile phone that supports WhatsApp.
Exclusion
- Being pregnant at the moment of signing informed consent.
- Being illiterate at the moment of signing informed consent.
- Being blind at the moment of signing informed consent
Key Trial Info
Start Date :
March 15 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2025
Estimated Enrollment :
131 Patients enrolled
Trial Details
Trial ID
NCT06500013
Start Date
March 15 2024
End Date
July 1 2025
Last Update
March 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Cayetano Heredia
Lima, Lima Province, Peru, 15102